MEDNAX, Inc. has eliminated the role of chief operating officer of the company, effective as of December 31, 2019, as part of the company’s previously announced transformation and restructuring plan. In connection with this change, the company’s chief operating officer, Mr. David A. Clark, departed the company on January 13, 2020, also effective as of December 31, 2019. Mr. Clark’s departure from the company is a termination without “Cause,” as defined in that certain employment agreement, dated February 12, 2019, by and between a wholly-owned subsidiary of the company and Mr. Clark.